Prior Radiation in Subjects Who Were Treated With Toca 511 and Toca FC Across 3 Toca 511 Phase 1 Trials

被引：0
|
作者：
Cloughesy, T. F. [1 ]
Aghi, M. [2 ]
Bota, D. [3 ]
Chen, C. [4 ]
Elder, J. B. [5 ]
Kalkanis, S. N. [6 ]
Kaptain, G. J. [7 ]
Kesari, S. [8 ,9 ]
Landolfi, J. [10 ]
Mikkelsen, T. [6 ]
Portnow, J. [11 ]
Robbins, J. M. [12 ]
Ostertag, D. [12 ]
Chu, A. [12 ]
Huang, T. [12 ]
Vogelbaum, M. A. [13 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] UCSF, San Francisco, CA USA
[3] UCI, Irvine, CA USA
[4] Univ Calif San Diego, La Jolla, CA 92093 USA
[5] Ohio State Univ, Columbus, OH 43210 USA
[6] Henry Ford Hosp, Detroit, MI 48202 USA
[7] Hackensack Univ, Med Ctr, Hackensack, NJ USA
[8] Univ Calif San Diego, San Diego, CA USA
[9] John Wayne Canc Inst, Santa Monica, CA USA
[10] JFK Med Ctr, Edison, NJ USA
[11] City Hope Natl Med Ctr, Duarte, CA USA
[12] Tocagen Inc, San Diego, CA USA
[13] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.758
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2160
引用
收藏
页码：E66 / E67
页数：2
相关论文
共 50 条
  • [1] Toca 511 and Toca FC in patients with gastrointestinal tumors in the Toca 6 study.
    Merchan, Jaime R.
    Ostertag, Derek
    Jolly, Douglas J.
    Tejera, Dalissa
    Gruber, Harry E.
    Shorr, Jolene
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [2] Toca 511 Followed by Toca FC in Subjects with Recurrent High Grade Glioma (HGG)
    Aghi, Manish K.
    Vogelbaum, Michael
    Cloughesy, Timothy
    Kesari, Santosh
    Portnow, Jana
    Ostertag, Derek
    Keller, Mary Rose
    Chu, Alice
    Skillings, Jamey
    Kaptain, George
    JOURNAL OF NEUROSURGERY, 2016, 124 (04) : A1154 - A1154
  • [3] Toca 6: A phase 1b study of Toca 511 and Toca FC in patients with advanced solid tumors or lymphoma.
    Merchan, Jaime R.
    Ahnert, Jordi Rodon
    Falchook, Gerald
    Ostertag, Derek
    Tejera, Dalissa
    Gruber, Harry E.
    Jolly, Douglas J.
    Shorr, Jolene
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] TOCA 511 & TOCA FC: PRE-CLINICAL PROOF OF CONCEPT IN MEDULLOBLASTOMA
    Richardson, Angela M.
    Collins, Sara A.
    Inagaki, Akihito
    Armstrong, L.
    Roussel, Martine
    Jolly, Douglas
    Robbins, David J.
    Ayad, Nagi
    Kasahara, Noriyuki
    NEURO-ONCOLOGY, 2017, 19 : 193 - 193
  • [5] Therapeutic Activity of Gene Therapy with Toca 511 & Toca FC for Esophageal Cancer
    Suzuki, Tomohiro
    Hiraoka, Kei
    Inoko, Kazuho
    Inagaki, Akihito
    Sasaki, Katsunori
    Kushiya, Hiroki
    Umemoto, Kazufumi
    Sato, Osamu
    Nakamura, Toru
    Tsuchikawa, Takahiro
    Shichinohe, Toshiaki
    Boyle, Nicholas A.
    Jolly, Douglas J.
    Gruber, Harry E.
    Kasahara, Noriyuki
    Hirano, Satoshi
    MOLECULAR THERAPY, 2019, 27 (04) : 132 - 133
  • [6] Immune modulation after Toca 511 and Toca FC treatment of colorectal cancer patients
    Falchook, Gerald Steven
    Ahnert, Jordi Rodon
    Venkat, Shree
    Donahue, Arthur
    Horner, Peder
    Thomassen, Amber
    Accomando, William
    Rodriguez-Aguirre, Maria
    Bentley, Cornelia
    Hogan, Daniel
    Ostertag, Derek
    Yavrom, Sharon
    Kheoh, Thian
    Jolly, Douglas J.
    Gruber, Harry E.
    Shorr, Jolene
    Merchan, Jaime R.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [7] Encouraging survival with Toca 511 and Toca FC compared to external lomustine control.
    Cloughesy, Timothy Francis
    Aghi, Manish K.
    Chen, Clark
    Elder, J. Bradley
    Kesari, Santosh
    Kalkanis, Steven N.
    Kaptain, George
    Landolfi, Joseph C.
    Mikkelsen, Tom
    Portnow, Jana
    Robbins, Joan M.
    Ostertag, Derek
    Das, Asha
    Chu, Alice
    Vogelbaum, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Durable complete responses in some recurrent highgrade glioma patients treated with Toca 511+Toca FC
    Cloughesy, Timothy F.
    Landolfi, Joseph
    Vogelbaum, Michael A.
    Ostertag, Derek
    Elder, James B.
    Bloomfield, Stephen
    Carter, Bob
    Chen, Clark C.
    Kalkanis, Steven N.
    Kesari, Santosh
    Lai, Albert
    Lee, Ian Y.
    Liau, Linda M.
    Mikkelsen, Tom
    Nghiemphu, Phioanh
    Piccioni, David
    Accomando, William
    Diago, Oscar R.
    Hogan, Daniel J.
    Gammon, Dawn
    Kasahara, Noriyuki
    Kheoh, Thian
    Jolly, Douglas J.
    Gruber, Harry E.
    Das, Asha
    Walbert, Tobias
    NEURO-ONCOLOGY, 2018, 20 (10) : 1383 - 1392
  • [9] Early clinical trials of Toca 511 and Toca FC show a promising novel treatment for recurrent malignant glioma
    Philbrick, Brandon D.
    Adamson, D. Cory
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (03) : 207 - 216
  • [10] A phase Ib study of Toca 511, a retroviral replicating vector, followed by Toca FC in patients with advanced cancer
    Merchan, Jaime
    Rodon, Jordi
    Falchook, Gerald
    Venkat, Shree
    Ostertag, Derek
    Tejera, Dalissa
    Kheoh, Thian
    Jolly, Douglas J.
    Gruber, Harry E.
    Shorr, Jolene S.
    CANCER RESEARCH, 2018, 78 (13)
12345